Azoximer bromide

Azoximer bromide
Clinical data
Other names	Polyoxidonium, Synpol
ATC code	L03AX (WHO) ;
Pharmacokinetic data
Bioavailability	up to 89%
Elimination half-life	25.4 hours (intravenous routes)
Identifiers
	IUPAC name Poly[[1-(carboxymethyl)piperazin-1-ium-1,4-diyl bromide]ethylene- co-[(piperazin-1,4-diyl 1-oxide)ethylene]];
CAS Number	892497-01-7;
ChemSpider	none;
UNII	90G53638ZD;
Chemical and physical data
Formula	[[C8H15BrN2O2]x[C6H12N2O]y]n
Molar mass	60000–100000 g/mol

Azoximer bromide, sold by the trade name Polyoxidonium, is a macromolecular compound with high-molecular weight and high immunomodulating activity. It is used in Russia and CIS in treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative.

Azoximer bromide is registered in US Patent-5503830 from 1996,^[1]^[2]^[3] in the Russian Federation from 1996, under registration number 96/302/9, FS 42-3906-00.^[4]

History

Polyoxidonium was created at the State Scientific Center of the Institute of Immunology of the Ministry of Health of the Russian Federation^[5]. It is produced by NPO Petrovax Pharm LLC^[6].

Medical uses

In adults with secondary immunodeficient states as:

relapsing chronic bacterial infections
relapsing chronic viral infections
acute bacterial infections
acute viral infections
allergic diseases (pollinosis, bronchial asthma, atopic dermatitis)
severe septic states
postoperative complications - purulent infections
when primary treatment develops cellular immunity decrease (cytostatic treatment, X-rays)

References

^ https://www.google.com/patents/about?id=s9cfAAAAEBAJ&dq=US+5503830
^ http://www.wikipatents.com/US-Patent-5503830/compounds-having-immunostimulating-activity-and-methods-of-use-thereof^{[permanent dead link]}
^ http://www.freepatentsonline.com/EP0789586.html
^ State Scientific Centre of Russian federation, Immunological Institute of Russian Federation Health Resort, CLINICAL ASPECTS OF USE OF IMMUNOMODULATOR POLYOXIDONIUM, Methodical handbook for doctors issued by State Scientific Centre of Russian Federation – Immunological Institute of Russian Federation Health Resort Moscow – 2003
^ Некрасов А. В., Пучкова Н. Г., Иванова А. С. и др. Производное поли-1,4-этиленпиперазина, обладающее иммуномодулирующей, противовирусной и антибактериальной активностью. Пат. РФ № 2073031, 1997.
^ http://petrovax.com/medication/catalog/polyoxydonium/

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

[1] ttps://www.google.com/patents/about?id=s9cfAAAAEBAJ&dq=US+5503830

[2] ttp://www.wikipatents.com/US-Patent-5503830/compounds-having-immunostimulating-activity-and-methods-of-use-thereof^{[permanent dead link]}

[3] ttp://www.freepatentsonline.com/EP0789586.html

[4] State Scientific Centre of Russian federation, Immunological Institute of Russian Federation Health Resort, CLINICAL ASPECTS OF USE OF IMMUNOMODULATOR POLYOXIDONIUM, Methodical handbook for doctors issued by State Scientific Centre of Russian Federation – Immunological Institute of Russian Federation Health Resort Moscow – 2003

[5] Некрасов А. В., Пучкова Н. Г., Иванова А. С. и др. Производное поли-1,4-этиленпиперазина, обладающее иммуномодулирующей, противовирусной и антибактериальной активностью. Пат. РФ № 2073031, 1997.

[6] ttp://petrovax.com/medication/catalog/polyoxydonium/

[1]

[2]

[3]

[4]

[5]

[6]